Kangmei Pharma | 600518 - 負債





負債 変化する 日付
Akebia Therapeutics USD 46.51M 7.82M 2025-03
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Avita Medical AUD 46.05M 1.46M 2025-12
Cspc Pharmaceutical CNY 495M 12.33M 2025-06
Dianthus Therapeutics USD 1.28M 45K 2025-09
Genomma Lab Internacional MXN 8.06B 488.83M 2026-03
Hypermarcas BRL 8.86B 535.71M 2025-06
Ionis Pharmaceuticals USD 2.34B 9.5M 2026-03
IQVIA Holdings USD 15.83B 109M 2026-03
Jiangsu Hengrui CNY 74.23M 17.2M 2025-12
Kangmei Pharma CNY 173.71M 42.08M 2026-03
Moderna USD 1.31B 571M 2025-12
Organon & Co USD 8.64B 184M 2025-12
Revvity USD 3.4B 29.2M 2025-12
Sh Fosun Pharma CNY 38.09B 1.1B 2025-12
Tectonic Therapeutic USD 876K 115K 2024-12
Viatris USD 14.34B 69.3M 2026-03
Wuxi Apptec CNY 8.38B 41.18M 2026-03
Xeris Pharmaceuticals USD 257.65M 431K 2025-09
Zz Pientze Pharmaceu CNY 1.07B 2.82M 2026-03